Core Viewpoint - Recently, LuKang Pharmaceutical announced that it and its subsidiary, Shandong LuKang Pharmaceutical Group Saiter Co., Ltd., have won bids for certain drugs in the national centralized procurement process [1] Group 1 - The announcement was made on the evening of November 7 [1] - The national organization for drug procurement released a notification regarding the results of the centralized procurement [1] - The procurement is identified as GY-YD2025-1 [1]